InvestLog
ARQT logo

ARQT

Arcutis Biotherapeutics, Inc.NASDAQHealthcare
$23.63-1.95%ClosedMarket Cap: $2.93B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-02Mizuho—Outperform—
2026-02-27Guggenheim—Buy—
2026-02-26HC Wainwright & Co.—Buy—
2026-02-26TD Cowen—Buy—
2026-02-26Needham—Buy—
2026-01-26Needham—Buy—
2025-11-28Mizuho—Outperform—
2025-10-30Goldman Sachs—Neutral—
2025-10-28Needham—Buy—
2025-08-07Needham—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$1.21$643.3M5
Sun Dec 31$1.99$782.9M6
Mon Dec 31$2.63$920.5M4
Tue Dec 31$3.06$1.06B2